PEPVERAAUTHENTIC HIGH-QUALITY PEPTIDES
SIGN IN
I

Buy from a supplier you can actually verify.

Pondere, non fabula.By weight, not story.
Vetted suppliers9across US · CN · EU · UK · AU · RU
Compounds77+GLP-1 · GH · longevity · cognition
Destinations23US · CA · UK · EU · AU · NZ · KR · JP · SG
Published COAs5 / 9Suppliers that publish a public sample COA
Labs cited across supplier profiles · coverage varies
3 CLIA-certified labsBioRegenFreedom DiagnosticsILS LaboratoriesUK-based ISO 17025 lab
Every supplier namedCompare in one rowOne cart, paid once
II

Already live.

Live supplier compare

9 suppliers and 77+ compounds, side by side. Open /browse.

Open /browse →
Sanctions screening, live

Every order passes OFAC and OpenSanctions at checkout.

Open /policy/terms →
Escrow settlement, live

USDC on Base held until delivery. Refund window applies before release.

Open /policy/refund →
Open data gaps, logged

Every unverified claim catalogued in an internal log. The list grows.

An empty ledger by design

Zero testimonials, zero invented batch records. The page fills when the first vial lands.

Jump to ledger →
No token, wholesale margin

Wholesale margin in USDC. No token, presale, or governance.

Acta, non verba.Deeds, not words.
III

The asset that compounds.

Each shipment leaves a verifiable record. Enough records become the data layer the category runs on, and no entrant can catch up without rebuilding the archive.

IToday

The aggregator

9 suppliers compared in one row, USDC escrow per order.

IIYear 2 to 3

The research workstation

COA archive, price alerts, cited literature on every mechanism.

IIIYear 4 to 5

The data layer

Other peptide sites display a PEPVERA-verified mark or lose trust.

Quae crescunt.What compounds.
IV

What incumbents cannot ship.

Off-label FDA exposure locks Amazon and Walmart out. PEPVERA holds five bright lines and inherits the moat.

  • No dose recommendations.
  • No protocol design.
  • No condition matching.
  • No human-use guidance.
  • Cite or refuse on every mechanism claim.

See the research-only disclaimer for the full text.

Vox studii, non medici.The voice of study, not a doctor.
V

Concrete through 2027 Q1. Redacted beyond.

2026 Q2NOW
  • Catalog, checkout, and escrow live
  • 9 suppliers, 77+ compounds, side by side
  • Refund, dispute mediation, and OFAC screening in production
2026 Q4
  • COA archive Phase one, one hundred verified batch records
  • PEPVERA Assistant private beta
  • Supplier coverage to thirty-five
2027 Q1
  • PEPVERA Assistant public
  • Subscription tier, price and batch alerts
  • Supplier coverage to fifty
2027 Q2
  • Independent ISO-17025 lab partnership
  • European and United Kingdom fulfillment infrastructure
  • ░░░░░░░░░░░░░░░░░░
2027 H2
  • ░░░░░░░░░░░░░░░░░░
  • Compound coverage to two hundred
  • ░░░░░░░░░░░░░░░░░░
2028 →DATA LAYER
  • ░░░░░░░░░░░░░░░░░░
  • ░░░░░░░░░░░░░░░░░░
Repeat rate

Ninety-day buyer return.

COA depth

Verified batch records archived.

Data-layer requests

API calls from external sites. ░░░░ launch target.

Marmore et numero.In marble and number.
VI

Every batch, on record.

Empty until the first shipment lands. Each batch ID and COA logged when it does.

Quod missum, hic.What was shipped, here.

9 suppliers. One row.

Browse compounds →